Microbiology Nuts & Bolts
  • Home
  • Basic Concepts
    • What is infection?
    • Normal flora
    • Diagnosing infection
  • Microbiology
    • Basic bacterial identification
    • Interpreting bacteriology results
    • Interpreting serology results
  • Infection Control
    • What is infection control?
    • Universal precautions
    • MRSA
    • Clostridium difficile
  • Clinical Scenarios
    • Respiratory infections
    • Urinary infections
    • GI infections >
      • D&V
      • CDAD
    • CNS infections
    • Skin & bone infections
    • Sepsis
  • Antibiotics
    • Antimicrobial Stewardship
    • How antibiotics work
    • How to choose an antibiotic?
    • Reviewing antibiotics
    • Antibiotic resistance
    • Testing antibiotic resistance
    • Penicillin allergy
    • Theraputic Drug Monitoring
  • Guidelines
  • Lectures & Lecture Notes
    • Medical Students
    • Curriculum for the Foundation Program
    • Foundation Year 1
    • Foundation Year 2
    • Other Lectures
  • The Bug Blog
  • Buy the book...
  • NEW Edition Updates
  • Peer Reviews
  • Want to know more?
  • Contact

Retirement Planning - Why antimicrobial resistance is important to me!?

2/9/2022

 
This may seem like a strange question for a Microbiologist to ask but it’s not as straight forward as many people think. I have blogged about this kind of thing before, but recent conversations with other healthcare workers have shown me that many still do not understand the effect that antimicrobial resistance is going to have on the wider scope of medicine. Well, it’s my blog so I’m going to blog about it again… 😊
 
Most people, including healthcare workers, think that antimicrobial resistance’s biggest threat is related to our ability to treat common infections such as pneumonia, urinary tract infections or cellulitis, but I think that is incorrect. Don’t get me wrong, it’s still important, but for me it’s not the most important threat from antimicrobial resistance.
 
Before I tell you what I think the biggest threats are, let me tell why treating common infections isn’t the biggest threat…
Post Antimicrobial Era - Retirement Planning
​Common infections
Common infections are common. Okay, that’s obvious, but look at it another way. Common infections are SO COMMON that if they had a tendency to kill people then the human race would have died out years ago! There are 15,000x more bacteria on 1 person than there are people on the planet… and that doesn’t even take into account all the other microorganisms in the environment or on other animals… if you don’t like viruses, bacteria, parasites and fungi you’re living on the wrong planet….
 
We have only had antibiotics for the past 100 years of our existence and yet we have managed to survive and multiply and spread around the World for 6-7 million years before this. The pre-antibiotic era will be essentially the same as an antibiotic resistance era in terms of the treatment of common infections. Common infections have had millions of years to wipe out the human race and yet they haven’t. In fact, the tendency of most infections is to get better without any antimicrobial treatment.
 
Most of the reduction in illness and death from common infections was down to improvements in public health, not antimicrobials. A good example of this is tuberculosis. Look at the graph below showing the mortality rate from TB in the 20th Century. Mortality came crashing down (with a couple of noticeable blips during wartime) during the first half of the century, and even though Streptomycin, the first drug active against tuberculosis, was discovered by Selman Waksman in the late 1940s, it didn’t become routinely available until the 1950s. By that stage the mortality from TB had already reduced dramatically, and all of this was due to improved public health.
TB deaths over time
Click for larger image
​Now that isn’t to say that we won’t see illness and death due to antimicrobial resistant organisms causing common infections, but rather this will not be the “biggest problem” as we will still tend to recover without any antimicrobials.
 
The No. 1 threat from antimicrobial resistance - surgery
For me the number 1 threat from antimicrobial resistance is surgery… even though the Royal College of Surgeons refused to review our book “Microbiology Nuts and Bolts” when it was first published because “it didn’t affect them”… they are simply wrong.
 
Every time a surgeon cuts into a non-sterile body site such as the gastrointestinal, urogenital or respiratory tracts, antimicrobial prophylaxis is given to prevent any serious infections from developing. If a surgeon is putting in any prosthetic material such as a prosthetic joint, heart valve or even a device like a pacemaker, antimicrobial prophylaxis is given to prevent the prosthesis getting infected. Also, there will be no operations on sites where infection might be unlikely, but the consequences would be devastating such as the brain e.g. removing benign tumours, repairing aneurysms, or putting in ventriculoperitoneal shunts.
 
If there are no antimicrobials left, then there will be no surgery on non-sterile sites. There will be no surgery to implant prosthetic material. There will be no neurosurgery.
 
Antimicrobial resistance will pretty much wipe out the surgical disciplines, leaving behind a few brave souls willing to risk everything doing painstakingly slow operations to try and prevent any risk of infection, and only when there is absolutely no alternative. Discomfort, disabilities, deformities and deaths will be common.
 
The No. 2 threat from antimicrobial resistance - cancer
I think the number 2 threat from antimicrobial resistance is cancer. There are essentially two ways to treat cancer, cut out the tumour or kill it with chemotherapy.
 
We’ve already seen that antimicrobial resistance will prevent many surgical operations to remove tumours, but it will also affect the type of chemotherapy that can be given.
 
Most chemotherapy aims to selectively kill cancer cells, but the selectivity is often only partial. Many other cells are also killed as innocent bystanders, and the rapidly dividing cells, such as those that make up the immune system, are particularly prone to being affected by chemotherapy.
 
Once the immune system has been “knocked down” the patient is at risk of infection, both with common virulent microorganisms and also less virulent opportunistic microorganisms. In this situation antimicrobials are key because the patients’ own immune system is not able to fight the infection. In these cases even common infections that don’t normally cause deaths can be lethal.
 
If we don’t have any effective antimicrobials due to resistance, then we won’t be able to operate to remove cancers and we won’t be able to give chemotherapy because the subsequent infections will kill the patient.
 
We also give antimicrobial prophylaxis to patients being treated for cancer to try and prevent infections occurring but, you’ve guessed it, these won’t be able to be given as they will not be effective; antimicrobial prophylaxis just won’t work.
 
The net result of this will be that people will die from currently treatable cancers and the mortality from cancer will shoot up. It won’t necessarily be the cancer itself causing the problem but the infections.
 
The No. 3 threat from antimicrobial resistance – empirical treatments
The number 3 threat from antimicrobial resistance is empirical treatment of infections, or rather the failure of empirical treatment of infections.
 
If a patient has an infection the doctor looking after them usually starts what is known as empirical treatment; the best “educated” guess at what should work to treat the patient with their group of similar symptoms or disease. The doctor doesn’t know the exact cause, so they look at a guideline that tells them what to start to cover the most common causes of that type of infection. In the UK these guidelines are often written by Microbiologists, and they are based on the common causes, possible adverse effects of the treatment options (such as Clostridium difficile associated disease) and the local and national antimicrobial resistance rates (it might surprise you that we don’t just “make them up”!). If there is a lot of resistance to antimicrobials, then the empirical treatment needs to change.
 
As antimicrobial resistance increases, the available pool of antimicrobials reduce… currently the pool is getting shallower as drug companies are no longer making new antimicrobials. Eventually the pool will be empty and there will be no empirical antimicrobial options left.
Post antimicrobial pool
Now if someone comes into hospital with septic shock the mortality increases by 6% for every hour they are not on an effective antimicrobial. We talk about the “golden hour” which is the first hour of the patients care when “effective” antimicrobials must be given to try and save the patient’s life. The initial choice of antimicrobial is empirical. Now if antimicrobial resistance means the initial antimicrobial isn’t effective against the cause of the patient’s septic shock, then the risk of that patient dying will increase dramatically (to over 40%) before the doctors are even aware that the empirical treatment isn’t going to work… it takes over 24 hours for the first Microbiology samples to grow bacteria and by then it will be too late.
 
So, the patient may have an otherwise treatable cause of their septic shock, such as a urinary tract infection or cholangitis, yet they will die because there were no effective antimicrobials available because of resistance.
 
So, there you have it. The Nuts & Bolts doom and gloom guide to the end of the antibiotic era… cheerful huh?! Well, looking on the bright side… if there are no antimicrobials left there will probably be no real need for Microbiologists and I can retire… just a thought… 😊
 
PS This retirement plan has not been approved by my financial advisor!

Comments are closed.

    RSS Feed

    Facebook has deleted the Microbiology Nuts & Bolts pages - if you want your weekly dose of microbiology then you will need to come here, and we look forward to you continuing to read it!

    Blog Author:

    David Garner
    Consultant Microbiologist
    Surrey, UK

    Please DO NOT advertise products and conferences on our website or blog

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    Archives

    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    October 2013
    September 2013
    August 2013
    July 2013

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    RSS Feed

Powered by Create your own unique website with customizable templates.